TORNTPHARM.BOTORNTPHARM.BO
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
5.78%
↑ 142% above average
Average (39q)
-13.69%
Historical baseline
Range
High:169.76%
Low:-472.28%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 5.78% |
| Q2 2025 | -42.66% |
| Q1 2025 | 0.93% |
| Q4 2024 | -5.71% |
| Q3 2024 | 2.91% |
| Q2 2024 | 5.11% |
| Q1 2024 | -0.28% |
| Q4 2023 | 3.44% |
| Q3 2023 | 3.96% |
| Q2 2023 | 63.56% |
| Q1 2023 | -33.93% |
| Q4 2022 | 7.05% |
| Q3 2022 | -0.87% |
| Q2 2022 | 89.02% |
| Q1 2022 | -36.84% |
| Q4 2021 | -6.26% |
| Q3 2021 | -1.25% |
| Q2 2021 | 11.10% |
| Q1 2021 | -2.67% |
| Q4 2020 | -2.34% |
| Q3 2020 | -5.67% |
| Q2 2020 | 9.33% |
| Q1 2020 | -0.91% |
| Q4 2019 | -1.94% |
| Q3 2019 | 3.49% |
| Q2 2019 | 5.31% |
| Q1 2019 | -0.74% |
| Q4 2018 | 4.38% |
| Q3 2018 | 3.21% |
| Q2 2018 | 95.30% |
| Q1 2018 | -38.29% |
| Q4 2017 | 12.24% |
| Q3 2017 | 1.97% |
| Q2 2017 | 169.76% |
| Q1 2017 | -459.26% |
| Q4 2016 | -6.90% |
| Q3 2016 | -29.27% |
| Q2 2016 | 117.96% |
| Q1 2016 | -472.28% |
| Q4 2015 | -15.47% |